Recombine Receives $995,000 New Funding

  • Feed Type
  • Date
    10/16/2015
  • Company Name
    Recombine
  • Mailing Address
    1140 Broadway New York, NY 10001 USA
  • Company Description
    Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine’s genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers.
  • Website
    http://www.recombine.com
  • Transaction Type
    Debt
  • Transaction Amount
    $995,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy